Page last updated: 2024-11-02

pd 98059 and Sclerosis, Systemic

pd 98059 has been researched along with Sclerosis, Systemic in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HJ1
Song, SB1
Choi, JM1
Kim, KM1
Cho, BK1
Cho, DH1
Park, HJ1
Yamane, K1
Ihn, H1
Kubo, M1
Tamaki, K1

Other Studies

2 other studies available for pd 98059 and Sclerosis, Systemic

ArticleYear
IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway.
    The Journal of investigative dermatology, 2010, Volume: 130, Issue:3

    Topics: Cells, Cultured; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Dermi

2010
Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:9

    Topics: Activin Receptors, Type I; Cells, Cultured; Chromones; Collagen Type I; Enzyme Inhibitors; Fibroblas

2002